1. Home
  2. ICUCW vs PRDO Comparison

ICUCW vs PRDO Comparison

Compare ICUCW & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • PRDO
  • Stock Information
  • Founded
  • ICUCW N/A
  • PRDO 1994
  • Country
  • ICUCW United States
  • PRDO United States
  • Employees
  • ICUCW 19
  • PRDO N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • PRDO Other Consumer Services
  • Sector
  • ICUCW Health Care
  • PRDO Real Estate
  • Exchange
  • ICUCW Nasdaq
  • PRDO Nasdaq
  • Market Cap
  • ICUCW N/A
  • PRDO N/A
  • IPO Year
  • ICUCW 2021
  • PRDO N/A
  • Fundamental
  • Price
  • ICUCW $0.03
  • PRDO $31.22
  • Analyst Decision
  • ICUCW
  • PRDO Buy
  • Analyst Count
  • ICUCW 0
  • PRDO 1
  • Target Price
  • ICUCW N/A
  • PRDO $38.00
  • AVG Volume (30 Days)
  • ICUCW N/A
  • PRDO 536.7K
  • Earning Date
  • ICUCW N/A
  • PRDO 05-01-2025
  • Dividend Yield
  • ICUCW N/A
  • PRDO 1.67%
  • EPS Growth
  • ICUCW N/A
  • PRDO N/A
  • EPS
  • ICUCW N/A
  • PRDO 2.25
  • Revenue
  • ICUCW N/A
  • PRDO $726,003,000.00
  • Revenue This Year
  • ICUCW N/A
  • PRDO $23.24
  • Revenue Next Year
  • ICUCW N/A
  • PRDO $5.00
  • P/E Ratio
  • ICUCW N/A
  • PRDO $13.85
  • Revenue Growth
  • ICUCW N/A
  • PRDO 6.35
  • 52 Week Low
  • ICUCW N/A
  • PRDO $20.23
  • 52 Week High
  • ICUCW N/A
  • PRDO $31.22
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • PRDO 73.28
  • Support Level
  • ICUCW N/A
  • PRDO $30.81
  • Resistance Level
  • ICUCW N/A
  • PRDO $31.84
  • Average True Range (ATR)
  • ICUCW 0.00
  • PRDO 1.13
  • MACD
  • ICUCW 0.00
  • PRDO 0.35
  • Stochastic Oscillator
  • ICUCW 0.00
  • PRDO 89.05

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: